Literature DB >> 20584541

EMPoWarMENT: Edmonton pediatric warfarin self-management pilot study in children with primarily cardiac disease.

M E Bauman1, K Black, M L Bauman, A A K Bruce, S Kuhle, L Bajzar, M P Massicotte.   

Abstract

UNLABELLED: Increasing numbers of children require warfarin thromboprophylaxis. Home INR testing by the patient (PST) has revolutionized warfarin management. However, the family/patient must contact the health team for guidance for warfarin dosing. Patient self management(PSM) prepares a patient performing PST to take an active role in warfarin dosing. Adult studies demonstrate that PSM is safe and effective with improved adherence and treatment satisfaction quality of life (QOL).
OBJECTIVE: To estimate the safety and efficacy in children performing PSM or PST, to evaluate warfarin dose decision making in PSM, and warfarin related QOL.
METHODS: Warfarinized children performing PST for >3m were randomized to PST or PSM. The PSM group underwent warfarin management education and assumed independent warfarin management. INRs were collected for a year prior to and for 1 year of study to determine TTR and warfarin decision making. QOL was assessed through inventory completion and interviews.
RESULTS: 28 children were randomized and followed for 12 months. TTR was (83.9% pre/ post), and 77.7% pre to 83.0% post for PST and PSM (p=0.312). Appropriate warfarin decision making was 90% with no major bleeding episodes and no thromboembolic events. PSM was preferred by families.
CONCLUSIONS: PSM for children may be a safe and effective management strategy for warfarinized children. Clinical studies with larger sample size are required. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20584541     DOI: 10.1016/j.thromres.2010.05.024

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Well-managed warfarin is superior to NOACs.

Authors:  Murray Trusler
Journal:  Can Fam Physician       Date:  2015-01       Impact factor: 3.275

2.  Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients.

Authors:  Jenna M Faircloth; Kristin M Miner; Tarek Alsaied; Nicole Nelson; Julie Ciambarella; Tomoyuki Mizuno; Joseph S Palumbo; Alexander A Vinks; Gruschen R Veldtman
Journal:  J Thromb Thrombolysis       Date:  2017-07       Impact factor: 2.300

Review 3.  Self-monitoring and self-management of oral anticoagulation.

Authors:  Carl J Heneghan; Josep M Garcia-Alamino; Elizabeth A Spencer; Alison M Ward; Rafael Perera; Clare Bankhead; Pablo Alonso-Coello; David Fitzmaurice; Kamal R Mahtani; Igho J Onakpoya
Journal:  Cochrane Database Syst Rev       Date:  2016-07-05

Review 4.  Is self-monitoring an effective option for people receiving long-term vitamin K antagonist therapy? A systematic review and economic evaluation.

Authors:  Pawana Sharma; Graham Scotland; Moira Cruickshank; Emma Tassie; Cynthia Fraser; Christopher Burton; Bernard Croal; Craig R Ramsay; Miriam Brazzelli
Journal:  BMJ Open       Date:  2015-06-25       Impact factor: 2.692

Review 5.  International normalized ratio self-testing and self-management: improving patient outcomes.

Authors:  Matteo Pozzi; Julia Mitchell; Anna Maria Henaine; Najib Hanna; Ola Safi; Roland Henaine
Journal:  Vasc Health Risk Manag       Date:  2016-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.